ArticleAmerican health & drug benefits2019

The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab.

Diana Brixner et al.PubMed ↗Full text ↗

No numbers read from the abstract.